E27.3

Drug-induced adrenocortical insufficiency

Billable / specific

E27.3 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Includes (from E27)

  • Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Excludes1

Not coded here — never report together with this code.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E27)
  • galactorrhea (N64.3) (from E27)
  • gynecomastia (N62) (from E27)

Use additional code

Add a code to identify the following, if applicable.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Also known as

  • Hypofunction, adrenocortical, drug-induced
  • Insufficiency, insufficient, adrenocortical, drug-induced
  • Insufficiency, insufficient, adrenocortical, iatrogenic
  • Steroid, effects, insufficiency

Parent code

  • E27Other disorders of adrenal glandHeader

Related codes

  • E27.0Other adrenocortical overactivityBillable
  • E27.1Primary adrenocortical insufficiencyBillable
  • E27.2Addisonian crisisBillable
  • E27.4Other and unspecified adrenocortical insufficiencyHeader
  • E27.5Adrenomedullary hyperfunctionBillable
  • E27.8Other specified disorders of adrenal glandBillable
  • E27.9Disorder of adrenal gland, unspecifiedBillable

Browse